Asset Details
Do you wish to reserve the book?
Survival analysis in adult Burkitt Lymphoma in Colombia according to HIV status
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Survival analysis in adult Burkitt Lymphoma in Colombia according to HIV status
Do you wish to request the book?
Survival analysis in adult Burkitt Lymphoma in Colombia according to HIV status
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Survival analysis in adult Burkitt Lymphoma in Colombia according to HIV status
2025
Overview
Burkitt lymphoma is a highly aggressive Non-Hodgkin Lymphoma, is considered a rare tumor, accounts for only 1–2 % of adult lymphomas in North America. The two-year Overall survival rates was reported between 67 % and 84 %. Statistics from developing countries comes mainly from children studies in Africa where Burkitt Lymphoma is endemic. In Latin American countries, information about survival in adult population is scarce with limited number of patients and poor survival outcomes mainly in HIV associated Burkitt Lymphoma. The aim of this study is to evaluate survival in adults’ patients with BL, and HIV status in a Colombian cohort.
A retrospective cohort study was conducted to determine the demographic characteristics, treatment, and survival of adult Burkitt Lymphoma patients in Colombia. The study included adult patients diagnosed with Burkitt Lymphoma between 2004 and 2023, and calculate Overall survival and progression free survival of the population, and according to HIV status
83 patients were included for analysis with 49 (59 %) patients with a sporadic variant and 34 (41 %) with an immunodeficiency-associated variant. The median age at diagnosis was 40 years, IQR (30 – 52), The 36-months OS was 49.9 % (95 % CI; 39.6 – 62.9 %)), and 36-months PFS was 51.5 % (95 % CI¸41.5 – 64.5). For HIV patients 36-months OS was 41 % (95 % CI; 26.7 – 62.7 %) and 59.2 % (95 % CI; 45.8 – 76.6 %) HIV negative HR 1.72 (95 % CI; 0.93 – 1.19 (p = 0.08).
this study suggests an OS survival inferior than reported for developed countries with inferior survival rates in HIV patients
•The 36-month OS of 49.9 % was inferior compared with developed countries.•The HIV status could affect OS in BL HR 1.72 (95 % CI 0.93–1.19).•In the last 10 years the survival rates of HIV BL were improved by 11.2 %.
Publisher
Elsevier Ltd,Elsevier Limited
